Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune -- Ignore unavailable to you. Want to Upgrade?

To: James Mortensen who wrote (92)	1/22/1998 9:56:00 AM
From: James Mortensen	Respond to of 416

Here's a quote from today's press release, " "Thursday January 22, 8:19 am Eastern Time Company Press Release SOURCE: MedImmune, Inc. MedImmune Closes $66.3 Million Private Placement GAITHERSBURG, Md., Jan. 22 /PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI - news) today announced that it has closed the private placement of 1,700,000 new shares of common stock to institutional investors BB Biotech, Investor AB and INVESCO Trust Company resulting in net proceeds to MedImmune of $66.3 million. The private placement was self-managed by MedImmune and was first announced on January 13, 1998. MedImmune now has 26.2 million shares outstanding. " Jim